target,target_id,target_uniprot,target_species,ligand,ligand_id,ligand_species,ligand_pubchem_cid,smiles,inchi,inchikey,type,action,action_comment,endogenous,primary_target,concentration_range,affinity_parameter,affinity_high,affinity_median,affinity_low,original_affinity_units,original_affinity_low_nm,original_affinity_median_nm,original_affinity_high_nm,original_affinity_relation,assay_description,receptor_site,ligand_context,pubmed_id CCR9,66,P51686,Human,vercirnon,9046,,10343454,Clc1ccc(c(c1)C(=O)c1cc[n+](cc1)[O-])NS(=O)(=O)c1ccc(cc1)C(C)(C)C,"InChI=1S/C22H21ClN2O4S/c1-22(2,3)16-4-7-18(8-5-16)30(28,29)24-20-9-6-17(23)14-19(20)21(26)15-10-12-25(27)13-11-15/h4-14,24H,1-3H3",JRWROCIMSDXGOZ-UHFFFAOYSA-N,Allosteric modulator,Antagonist,,,yes,,pIC50,,8.22,,IC50,,6.0,,=,Measuring inhibition of antagonist tracer [3H]CCX807 binding to human Molt-4 cells.,,,20660125, CCR9,66,P51686,Human,compound 24 [PMID: 26987013 ],9252,,118197428,O=C1c2c(ccc(c2C(=O)N1c1ccc[n+](c1C)[O-])Cl)NS(=O)(=O)c1ccc(cc1)C(C)(C)C,"InChI=1S/C24H22ClN3O5S/c1-14-19(6-5-13-27(14)31)28-22(29)20-17(25)11-12-18(21(20)23(28)30)26-34(32,33)16-9-7-15(8-10-16)24(2,3)4/h5-13,26H,1-4H3",SEZYEWZALINSCW-UHFFFAOYSA-N,Antagonist,Antagonist,,,,,pKi,,8.22,,Ki,,6.0,,=,FLIPR calcium assay using MOLT4 cells,,,26987013,